Global Antibiotic Production Market, By Drug Origin (Natural, Semisynthetic, and Synthetic), Spectrum of Activity (Broad-Spectrum Antibiotic and Narrow-Spectrum Antibiotic), Route of Administration (Oral, Intravenous, and Others), Class (Beta Lactam and Beta Lactamase, Quinolones, Macrolides, and Others) – Industry Trends and Forecast to 2029
Antibiotic Production Market Analysis and Size
According to the United Nations' Ageing Population Report 2019, there were 962 million people in the globe who were 60 or older in 2017. In the UK, there were 447,694 sexually transmitted diseases (STIs) diagnoses in 2018, a 5% rise from 2017. In addition, there were 7,541 occurrences of syphilis reported in 2018, a 5% rise from 2017, and 56,259 infections of gonorrhoea, a 26 percent increase from 2017.
Data Bridge Market Research analyses that the antibiotic production market which was USD 40.70 billion in 2021, would rocket up to USD 61.29 billion by 2029, and is expected to undergo a CAGR of 5.25% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Antibiotic Production Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Drug Origin (Natural, Semisynthetic, and Synthetic), Spectrum of Activity (Broad-Spectrum Antibiotic and Narrow-Spectrum Antibiotic), Route of Administration (Oral, Intravenous, and Others), Class (Beta Lactam and Beta Lactamase, Quinolones, Macrolides, and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Abbott (U.S.), F.Hoffmann-La Roche Ltd (Switzerland), Allergan (Ireland), Amgen Inc. (U.S.), GSK plc. (U.K.), Merck Sharp & Dohme Corp. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Sanofi (France), Johnson & Johnson Private Limited (U.S.), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd (U.S.)
|
|
Market Opportunities
|
|
Market Definition
A particular class of antimicrobial agent that works against bacteria is an antibiotic. Antibiotic drugs are frequently employed in treating and preventing bacterial infections because they are the most effective type of antibacterial agent.
Antibiotic Production Market Dynamics
Drivers
- Increasing number of patients suffering from infectious diseases
The prevalence of infections and diseases, which is on the rise according to COVID-19, is a serious issue for the healthcare system and will increase the growth rate of the market for treatments.
- Development of extraordinary potential particles
On the other hand, introducing novel sequence treatments and developing extraordinary potential particles are anticipated to create lucrative prospects for business professionals.
- Rise in the geriatric population
The rising prevalence rates of lifestyle disorders like diabetes and obesity, rising health-care spending, and the fast-growing diagnostic industry are driving the expansion of the antibiotic production market.
Opportunities
Due to a number of factors, including strong initiatives taken by big firms for the expansion of high-level outputs, the market for antibiotic manufacture is anticipated to rise steadily. Other factors influencing market expansion include the increased use of antibiotics in low- and middle-income countries, large investments made by pharmaceutical companies in R&D projects, and an increase in the prevalence of communicable illnesses. Some factors are driving the expansion of the market.
Restraints/Challenges
Despite this, increased drug endorsement costs and improved antibiotic endurance will be anticipated to restrain market expansion.
This antibiotic production market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the antibiotic production market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Antibiotic Production Market
Additionally, antibiotics are the subject of intensive research because of the critical necessity for creating medications and treatments for COVID-19. For instance, in a coronavirus (COVID-19) clinical trial conducted in France, Pfizer reported good data for the use of its azithromycin (Zithromax) medication in combination with hydroxychloroquine in March 2020. Similarly, in three cohorts of patients treated with hydroxychloroquine alone, a combination of hydroxychloroquine and azithromycin, and supportive care alone, there was no significant difference in the risks associated with mechanical ventilation, according to a study of 368 patients published in April 2020.
Recent Development
- In October 2020, Arixa Pharmaceuticals Inc., a business focused on creating oral antibiotics of the next generation for drug-resistant Gram-negative infections, will be acquired by Pfizer Inc., according to an announcement made.
Global Antibiotic Production Market Scope
The antibiotic production market is segmented on the basis of drug origin, spectrum of activity, route of administration and class. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug Origin
- Natural
- Semisynthetic
- Synthetic
Spectrum of Activity
- Broad-Spectrum Antibiotic
- Narrow-Spectrum Antibiotic
Route of Administration
- Oral
- Intravenous
- Others
Class
- Beta Lactam and Beta Lactamase
- Quinolones
- Macrolides
- Others
Antibiotic Production Market Regional Analysis/Insights
The antibiotic production market is analysed and market size insights and trends are provided by country, drug origin, spectrum of activity, route of administration and class as referenced above.
The countries covered in the antibiotic production market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the antibiotic production market due to the growing number of geriatric population along with adoption of innovative medical technology.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the focus of various established market players to expand their presence in this particular region owed to the existence of lucrative market ground in terms of volume and revenue.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Antibiotic Production Market Share Analysis
The antibiotic production market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to antibiotic production market.
Some of the major players operating in the antibiotic production market are:
- Abbott (U.S.)
- F.Hoffmann-La Roche Ltd (Switzerland)
- Allergan (Ireland)
- Amgen Inc. (U.S.)
- GSK plc. (U.K.)
- Merck Sharp & Dohme Corp. (U.S.)
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S.)
- Johnson & Johnson Private Limited (U.S.)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd (U.S.)
- Sanofi (France)
SKU-